Grindwell Norton Limited (NSE:GRINDWELL)

Theseus Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	712.76	491.04	396.14	384.01	193
Short-Term Investments	-	1,909	1,619	972.5	2,376	1,088
Trading Asset Securities	-	6,159	4,473	4,352	3,303	5,214
Cash & Short-Term Investments	8,781	8,781	6,583	5,721	6,063	6,495
Cash Growth	33.39%	33.39%	15.06%	-5.64%	-6.65%	52.27%
Accounts Receivable	-	3,624	3,575	2,802	2,369	2,018
Other Receivables	-	162.04	88.92	7.3	93.19	124.95
Receivables	-	3,802	3,679	2,821	2,469	2,146
Inventory	-	4,899	4,876	4,639	4,476	3,225
Prepaid Expenses	-	41.88	49.79	41.22	42.97	12.56
Other Current Assets	-	495.54	545.94	562.91	727.38	589.58
Total Current Assets	-	18,019	15,733	13,785	13,778	12,469
Property, Plant & Equipment	-	8,177	7,896	6,149	4,418	3,850
Long-Term Investments	-	2,760	2,561	2,173	2,009	1,921
Goodwill	-	467.87	467.87	467.87	4.88	4.88
Other Intangible Assets	-	473.14	470.37	482.49	103.67	85.71
Long-Term Deferred Tax Assets	-	22.05	40.1	39.77	34.16	26.01
Other Long-Term Assets	-	520.08	449.58	939.17	806.53	282.84
Total Assets	-	30,568	27,696	24,099	21,193	18,647
Accounts Payable	-	4,253	3,624	2,792	3,277	3,118
Accrued Expenses	-	1,155	1,070	897.41	779.26	725.77
Short-Term Debt	-	43.68	66.91	85.9	-	-
Current Portion of Long-Term Debt	-	19.43	50	50	21.53	-
Current Portion of Leases	-	165.69	104.35	83.21	49.39	58.71
Current Income Taxes Payable	-	98.39	79	251.05	219.84	67.91
Current Unearned Revenue	-	365.38	422.79	435.74	312.37	226.8
Other Current Liabilities	-	257.48	287.06	377.07	225.18	158.05
Total Current Liabilities	-	6,358	5,703	4,973	4,885	4,355
Long-Term Debt	-	10.12	63.62	39.52	-	-
Long-Term Leases	-	596.57	541.09	255.02	80.02	62.78
Long-Term Unearned Revenue	-	42.24	3.1	4.2	5.61	7
Long-Term Deferred Tax Liabilities	-	363.78	220.99	138.53	155.05	193.15
Other Long-Term Liabilities	-	501.98	496.19	520.17	267.75	241.95
Total Liabilities	-	7,872	7,028	5,930	5,393	4,877
Common Stock	-	553.6	553.6	553.6	553.6	553.6
Additional Paid-In Capital	-	279.08	279.08	279.08	279.08	279.08
Retained Earnings	-	19,728	17,966	15,725	13,442	11,563
Comprehensive Income & Other	-	1,994	1,754	1,501	1,410	1,253
Total Common Equity	22,555	22,555	20,553	18,058	15,685	13,648
Minority Interest	-	140.49	115.04	110.75	115.65	121.34
Shareholders' Equity	22,695	22,695	20,668	18,169	15,800	13,770
Total Liabilities & Equity	-	30,568	27,696	24,099	21,193	18,647
Total Debt	835.49	835.49	825.96	513.65	150.93	121.48
Net Cash (Debt)	7,945	7,945	5,757	5,207	5,912	6,373
Net Cash Growth	38.02%	38.02%	10.55%	-11.92%	-7.24%	57.69%
Net Cash Per Share	71.75	71.76	51.99	47.03	53.40	57.56
Filing Date Shares Outstanding	110.73	110.72	110.72	110.72	110.72	110.72
Total Common Shares Outstanding	110.73	110.72	110.72	110.72	110.72	110.72
Working Capital	-	11,661	10,030	8,812	8,893	8,114
Book Value Per Share	203.71	203.71	185.63	163.10	141.66	123.27
Tangible Book Value	21,614	21,614	19,615	17,108	15,576	13,558
Tangible Book Value Per Share	195.21	195.21	177.15	154.51	140.68	122.45
Land	-	190.14	190.14	190.14	190.14	190.14
Buildings	-	2,749	2,438	2,088	1,806	1,642
Machinery	-	8,358	6,853	5,336	4,514	4,104
Construction In Progress	-	254.17	1,275	1,235	662.44	239.99
Leasehold Improvements	-	206.16	126.23	76.1	57.03	101.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.